...
首页> 外文期刊>Pediatric surgery international >Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia.
【24h】

Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia.

机译:植入式与袖带式外部中央静脉导管治疗急性淋巴细胞性白血病的儿童和青少年。

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL).All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient's first CVC.We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient's with ports (p < 0.001). Ports were significantly less likely to require removal prior to the end of treatment overall (p < 0.001) and for specific complications such as infection (p < 0.001) and dislodgement (p = 0.001). However, when adjusted for disease severity there is no difference in premature CVC removal rates.When patients are risk-stratified for disease severity there is no difference in rates of CVC removal prior to completion of treatment.
机译:这项研究的目的是确定完全植入式中心静脉导管(端口)和隧道式外部中心静脉导管(外部CVC)的并发症之间是否存在差异,这些并发症导致儿童和儿童的中心静脉导管(CVC)的早期切除。回顾性纳入1996年11月至2007年12月之间住院且患有CVC的ALL患儿的所有急性淋巴细胞性白血病(ALL)青少年。我们分析了有关患者首次CVC的数据。我们纳入了322名患者。 254个接收端口,68个接收外部CVC。有102例CVC并发症需要在完成化疗之前清除CVC(有端口的患者65例,有外部CVC的患者37例)。需要移除CVC的总体并发症在带有端口的患者中发生的可能性大大降低(p <0.001)。总体而言,在治疗结束前需要移除端口的可能性显着降低(p <0.001),并且对于特定的并发症,例如感染(p <0.001)和移位(p = 0.001),也不太可能。但是,如果根据疾病的严重程度进行了调整,则过早的CVC去除率没有差异。当对患者进行疾病风险等级的风险分层时,在完成治疗之前,CVC的去除率也没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号